NCT02405910View on ClinicalTrials.gov

Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 15, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

April 30, 2023

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

Nab-paclitaxel

DRUG

Gemcitabine

Trial Locations (1)

26506

West Virginia University Hospitals - Mary Babb Randolph Cancer Center, Morgantown

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

West Virginia University

OTHER